Sec. 17b-495. (Formerly Sec. 17a-346). Contract with fiscal intermediary. Reports.
Sec. 17b-495. (Formerly Sec. 17a-346). Contract with fiscal intermediary. Reports. (a) The commissioner may enter into an agreement with a fiscal intermediary
which may be an agency of the state, or a person, firm or public or nonprofit corporation,
for the administration of the whole or any part of the program. Any such contract shall
be subject to the provisions of sections 4a-57 and 4a-59, except that preference shall be
given to persons, firms or corporations doing business in the state.
(b) The contract shall require the fiscal intermediary to submit quarterly reports to
the commissioner on the operation of the program, including financial and utilization
statistics as to drug use by therapeutic category, actuarial projections, an outline of
problems encountered in the administration of the program and suggested solutions to
the same and any recommendations to enhance the program.
(c) The commissioner shall verify the propriety and reasonableness of payments to
providers, through field audit examinations and other reasonable means, to the extent
possible within available appropriations. The commissioner shall submit an annual report, on or before February first of each year, to the Secretary of the Office of Policy
and Management and the chairpersons of the joint standing committee of the General
Assembly having cognizance of matters relating to appropriations and the budgets of
state agencies outlining the program for carrying out such verifications and including
the results of such verifications.
(d) The commissioner shall submit biannual reports, in accordance with section 11-4a, to the Governor and the chairpersons of the joint standing committees of the General
Assembly having cognizance of matters relating to appropriations and the budgets of
state agencies and public health. Each report shall include a copy of the most recent
report of the fiscal intermediary, if any, and (1) the number of consumers eligible for
the program, (2) the number of consumers utilizing the program, (3) an outline of and
a report on the educational outreach program, (4) the number of appeals, (5) an outline
of problems encountered in the administration of the program and suggested solutions
and any recommendations to enhance the program.
(P.A. 85-573, S. 10, 18; 86-403, S. 92, 132; P.A. 87-3, S. 6, 9; P.A. 91-190, S. 2, 9; June Sp. Sess. P.A. 91-8, S. 50, 63;
P.A. 03-268, S. 10; P.A. 04-16, S. 13.)
History: P.A. 86-403 made technical change in Subsec. (b), substituting "commissioner" for "secretary"; P.A. 87-3
inserted new Subsec. (c) re verification of reasonableness of payments and relettered former subsection as (d), adding
provision re reporting to the advisory board; Sec. 17-517 transferred to Sec. 17a-346 in 1991; P.A. 91-190 amended Subsecs.
(c) and (d) to eliminate requirement that annual and quarterly reports be submitted to chairpersons of pharmaceutical
assistance advisory board established pursuant to Sec. 17a-341 to reflect repeal of said section; June Sp. Sess. P.A. 91-8
deleted references to the generic incentive dispensing fee in Subsec. (c); Sec. 17a-346 transferred to Sec. 17b-495 in 1995;
P.A. 03-268 amended Subsec. (d) to require that commissioner submit biannual reports rather than quarterly reports and
to add reference to Sec. 11-4a; P.A. 04-16 made a technical change in Subsec. (d).